Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
Alicia K. Morgans, Matthew D. Galsky, Phoebe Wright, Zsolt Hepp, Nancy N. Chang, Candice Willmon, Steve Sesterhenn, Yutong Liu, Guru Sonpavde
Topics & Concepts
MedicineCisplatinHazard ratioInternal medicineMetastatic Urothelial CarcinomaOncologyProportional hazards modelRetrospective cohort studyChemotherapyCancerUrothelial carcinomaBladder cancerConfidence intervalBladder and Urothelial Cancer TreatmentsEsophageal Cancer Research and TreatmentRenal cell carcinoma treatment